Jefferson Capital Reports Mixed Q1 Results: Record Revenue, Lower Net Income, Declares Dividend
JCAP sits 17% above its 52-week low of $15.98.
Summary
Jefferson Capital reported mixed first-quarter 2026 financial results, featuring record collections and revenue growth, an improved leverage ratio, and a declared dividend, despite a year-over-year decline in net income.
Key Events · Earnings and Guidance · JCAP
-
Q1 2026 Financial Results Announced
The company reported record quarterly collections of $309.9 million (up 19%) and record revenue of $176.4 million (up 14%) for the first quarter ended March 31, 2026.
-
Net Income and EPS Decline
Net income decreased to $37.6 million from $64.2 million in Q1 2025, with reported EPS of $0.61 and Adjusted EPS of $0.73.
-
Quarterly Cash Dividend Declared
The Board of Directors declared a quarterly cash dividend of $0.24 per share, payable on June 4, 2026.
-
Leverage Ratio Improved
The company's leverage ratio improved to 1.79x at March 31, 2026, compared to 2.17x at March 31, 2025.
Analysis · JCAP · Finance
Jefferson Capital reported mixed first-quarter 2026 financial results. The company achieved record collections and revenue growth, alongside an improved leverage ratio and a declared quarterly dividend. However, net income and adjusted net income declined year-over-year. Management expressed confidence in the investment environment and the company's strategic positioning. The filing also reiterated a recent credit facility upsize that was previously disclosed.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, JCAP was trading at $18.69 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $15.98 to $23.80. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.